Cargando…

Editorial: Prognosis prediction and risk stratification in head and neck cancer

Detalles Bibliográficos
Autores principales:	Li, Tengxiang, Lu, Jie, Yin, Yong, Qiu, Qingtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837104/ https://www.ncbi.nlm.nih.gov/pubmed/36644639 http://dx.doi.org/10.3389/fonc.2022.1037001

Ejemplares similares

Comparative analysis of dose calculation algorithms for CyberKnife-based stereotactic radiotherapy in lung cancer
por: Ge, Xuanchu, et al.
Publicado: (2023)

Editorial: Head and neck cancer in the elderly
por: Szturz, Petr, et al.
Publicado: (2023)

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group
por: Klinghammer, Konrad, et al.
Publicado: (2022)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Women in head and neck cancer 2021
por: Economopoulou, Panagiota, et al.
Publicado: (2022)

Editorial: Insights in head and neck cancer: 2021
por: Lybaert, Willem, et al.
Publicado: (2023)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

Editorial: Challenges and their implications for the clinical practice of head and neck cancer
por: Wirth, Markus, et al.
Publicado: (2023)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics
por: Kok, Victor C., et al.
Publicado: (2021)

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment
por: Vermorken, Jan B., et al.
Publicado: (2021)

Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer
por: You, Guo-Rung, et al.
Publicado: (2021)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
por: Argiris, Athanassios, et al.
Publicado: (2019)

Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis
por: Wang, Jia-Qi, et al.
Publicado: (2022)

Editorial: Identification, risk stratification, and optimized management for Lynch Syndrome
por: Bernstein, Inge, et al.
Publicado: (2023)

Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma
por: He, Yingzheng, et al.
Publicado: (2020)

Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”
por: Cao, Wei, et al.
Publicado: (2021)

LncRNA AL161431.1 predicts prognosis and drug response in head and neck squamous cell carcinoma
por: Zhou, Mingzhu, et al.
Publicado: (2023)

Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
por: Boguszewicz, Łukasz
Publicado: (2022)

Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Liu, Guohong, et al.
Publicado: (2021)

Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
por: Kanno, Yuzuka, et al.
Publicado: (2021)

Systematic Analysis and Identification of Dysregulated Panel lncRNAs Contributing to Poor Prognosis in Head-Neck Cancer
por: Tang, Shang-Ju, et al.
Publicado: (2021)

HNCDB: An Integrated Gene and Drug Database for Head and Neck Cancer
por: Zhang, Qingbin, et al.
Publicado: (2019)

Editorial: Advances in the Involvement of Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma
por: Lechien, Jerome R., et al.
Publicado: (2022)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
por: Li, Yongchao, et al.
Publicado: (2021)

HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification
por: Kimple, Adam J., et al.
Publicado: (2012)

Systemic Immun e–Inflammation Index as a Predictor for Head and Neck Cancer Prognosis: A Meta-Analysis
por: Wang, Yun-Ting, et al.
Publicado: (2022)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Editorial: Virtual surgical planning and 3d printing in head and neck tumor resection and reconstruction
por: Su, Yu-xiong, et al.
Publicado: (2022)

Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture?
por: Zhang, Wei-long, et al.
Publicado: (2019)

Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling
por: Li, Li-Jie, et al.
Publicado: (2022)

Sequence Variants and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium
por: Chuang, Shu-Chun, et al.
Publicado: (2011)

Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
por: Enokida, Tomohiro, et al.
Publicado: (2016)

Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck
por: Crombet Ramos, Tania, et al.
Publicado: (2020)

Research Progress of circRNAs in Head and Neck Cancers
por: Li, Panchun, et al.
Publicado: (2021)

Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy
por: Hamada, Seijiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ufs2r46cq336shj3rmdd0a34lt